| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.51 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |